What's New
New measures and advice to prevent topiramate exposure during pregnancy
Medsafe has published an alert communication on the new measures and advice to prevent topiramate exposure during pregnancy.
Do not use topiramate during pregnancy unless absolutely necessary.
Anyone who could get pregnant should use effective contraception while taking topiramate and for at least four weeks after the last dose.
News and Events
| Date | Type | Title |
|---|---|---|
| 7/1/2026 | Notices | Notice of Medsafe Office Closure Christmas/New Year 2025/2026 |
| 23/9/2025 | Alert Communication | Topiramate: New measures and advice to prevent exposure during pregnancy |
| 4/9/2025 | Committees | Classification Database was updated on 3 September 2025 |
| 4/9/2025 | Committees | Recent New Zealand Gazette Notices Relating to Classification |
| 4/9/2025 | Publications | Prescriber Update Vol. 46. No. 3 - September 2025 |
| 19/8/2025 | Notices | Medsafe performance statistics 2024/2025 |
| 13/8/2025 | Consultation | Clozapine: Proposed changes to blood monitoring and prescribing requirements - consultation questions for consumers and families - closes 8 October 2025 |
| 13/8/2025 | Consultation | Clozapine: Proposed changes to blood monitoring and prescribing requirements - consultation questions for healthcare professionals - closes 8 October 2025 |
